Related Experiment Video

Updated: Jun 14, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Results of treatment of multiple sclerosis with dicoumarin

T J PUTNAM, L V CHIAVACCI

    Archives of Neurology and Psychiatry
    |March 19, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    COUMARIN/therapySCLEROSIS/disseminated

    Related Concept Videos

    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...